Publication: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2). Journal: Lancet 105; 386(10008): 2059–68.
The EACPT is delighted to announce that the 2017 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Professor Pertti Neuvonen from Finland.
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning. Lancet 2014; 383(9918): 697–704.
The EACPT is delighted to announce that the 2015 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Michel Eichelbaum from Germany.
Publication: Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation. Journal: Lancet Neurology 2012; 11(7): 589–596
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Sir Michael Rawlins MD, PhD. from the United Kingdom.
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Carlo Patrono from Italy.
Publication: Genetic determinants of response to clopidogrel and cardiovascular events. Journal: New England Journal of Medicine.
The EACPT is delighted to announce that the 2011 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Sir Colin Dollery from the United Kingdom.
D Publication: Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Journal: Hypertension 2008; 51: 1476-82.